Impact of pay for performance on prescribing of long- Acting reversible contraception in primary care: An interrupted time series study

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Arrowsmith, Myat E ^a   Majeed, Azeem ^a   Lee, John Tayu ^a   Saxena, Sonia ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL CONTRACEPTIVE AGENT; SPERMICIDAL AGENT; CONTRACEPTIVE AGENT;

ADOLESCENT; ADULT; ARTICLE; CONTRACEPTION; FEMALE; GENERAL PRACTICE; HEALTH INSURANCE; HORMONAL CONTRACEPTION; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; LONG ACTING REVERSIBLE CONTRACEPTION; ORAL CONTRACEPTION; PRESCRIPTION; PRIMARY MEDICAL CARE; TIME SERIES ANALYSIS; UTERINE CERVIX CAP; VAGINA RING; CONTROLLED STUDY; ECONOMICS; ORGANIZATION AND MANAGEMENT; PRIMARY HEALTH CARE; RANDOMIZED CONTROLLED TRIAL; REIMBURSEMENT;

ADOLESCENT; ADULT; CONTRACEPTIVE AGENTS, FEMALE; FEMALE; HUMANS; PRIMARY HEALTH CARE; REIMBURSEMENT, INCENTIVE;

EID: 84898789819     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0092205     Document Type: Article

References (43)

1. National Institute of Clinical Excellence (NICE) (2005) CG 30 Long-acting Reversible Contraception: The effective and appropriate use of long-acting reversible contraception, Full Guideline.
2. Mansour D, Inki P, Gemzell-Danielsson K (2010) Efficacy of contraceptive methods: A review of the literature. The European Journal of Contraception and Reproductive Health Care 15: 4-16.
3. Trussell J (2009) Understanding contraceptive failure. Best Practice & Research Clinical Obstetrics & Gynaecology 23: 199-209.
4. Trussell J, Leveque JA, Koenig JD, London R, Borden S, et al. (1995) The economic value of contraception: a comparison of 15 methods. Am J Public Health 85: 494-503.
5. Mavranezouli I (2008) The cost-effectiveness of long-acting reversible contraceptive methods in the UK: analysis based on a decision-analytic model developed for a National Institute for Health and Clinical Excellence (NICE) clinical practice guideline. Hum Reprod 23: 1338-1345.
6. Trussell J, Lalla AM, Doan QV, Reyes E, Pinto L, et al. (2009) Cost effectiveness of contraceptives in the United States. Contraception 79: 5-14.
7. Sonfield A (2007) Popularity Disparity: Attitudes About The IUD in Europe and the United States. Guttmacher Policy Review. pp. 19-24.
8. United Nations (2011) World contraceptive use 2011 Department of Economic and Social Affairs, Population Division.
9. Peterson HB, Curtis KM (2005) Long-Acting Methods of Contraception. New England Journal of Medicine 353: 2169-2175. (Pubitemid 41653108)
10. Trussell J (2011) Contraceptive failure in the United States. Contraception 83: 397-404.
11. BMA & NHS Employers (2009) Quality and outcomes framework guidance for GMS contract 2009/10.
12. Roland M (2004) Linking Physicians' Pay to the Quality of Care - A Major Experiment in the United Kingdom. N Engl J Med 351: 1448-1454.
13. BMA & NHS Employers (2008) Quality and outcomes framework guidance for GMS contract 2008/09.
14. Doran T, Fullwood C, Gravelle H, Reeves D, Kontopantelis E, et al. (2006) Pay-for- Performance Programs in Family Practices in the United Kingdom. N Engl J Med 355: 375-384. (Pubitemid 44127540)
15. Campbell SM, Reeves D, Kontopantelis E, Sibbald B, Roland M (2009) Effects of Pay for Performance on the Quality of Primary Care in England. N Engl J Med 361: 368-378.
16. Downing A, Rudge G, Cheng Y, Tu Y-K, Keen J, et al. (2007) Do the UK government's new Quality and Outcomes Framework (QOF) scores adequately measure primary care performance? A cross-sectional survey of routine healthcare data. BMC Health Services Research 7: 166.
17. Gillam SJ, Siriwardena AN, Steel N (2012) Pay-for-performance in the United Kingdom: impact of the quality and outcomes framework: a systematic review. Ann Fam Med 10: 461-468.
18. Majeed A, Evans N, Head P (1997) What can PACT tell us about prescribing in general practice? BMJ 315: 1515-1519. (Pubitemid 27517182)
19. NICE (National Institute for Health and Clinical Excellence) (2005) Long-acting reversible contraception: the effective and appropriate use of long-acting reversible contraception. ROCG Press.
20. Serumaga B, Ross-Degnan D, Avery AJ, Elliott RA, Majumdar SR, et al. (2011) Effect of pay for performance on the management and outcomes of hypertension in the United Kingdom: interrupted time series study. BMJ 342.
21. Zhang F, Wagner AK, Soumerai SB, Ross-Degnan D (2009) Methods for estimating confidence intervals in interrupted time series analyses of health interventions. Journal of Clinical Epidemiology 62: 143-148.
22. Lee JT, Netuveli G, Majeed A, Millett C (2011) The Effects of Pay for Performance on Disparities in Stroke, Hypertension, and Coronary Heart Disease Management: Interrupted Time Series Study. PLoS ONE 6: e27236.
23. Wagner AK, Soumerai SB, Zhang F, Ross-Degnan D (2002) Segmented regression analysis of interrupted time series studies in medication use research. Journal of Clinical Pharmacy and Therapeutics 27: 299-309. (Pubitemid 34989269)
24. Moran JL, Solomon PJ, for the Adult Database Management Committee of the A, New Zealand Intensive Care S (2011) Conventional and advanced time series estimation: application to the Australian and New Zealand Intensive Care Society (ANZICS) adult patient database, 1993-2006. Journal of Evaluation in Clinical Practice 17: 45-60.
25. Glasier A, Scorer J, Bigrigg A (2008) Attitudes of women in Scotland to contraception: a qualitative study to explore the acceptability of long-acting methods. Journal of Family Planning and Reproductive Health Care 34: 213-217.
26. Gupta S, Miller JE (2000) A survey of GP views on intra-uterine contraception. British Journal of Family Planning 26: 81-84. (Pubitemid 30204245)
27. Alabbadi I, Crealey G, Turner K, Rafferty T, Keenan L, et al. (2010) Statin prescribing in Northern Ireland and England pre and post introduction of the quality and outcomes framework. Pharmacy World & Science 32: 43-51.
28. MacBride-Stewart SP, Elton R, Walley T (2008) Do quality incentives change prescribing patterns in primary care? An observational study in Scotland. Family Practice 25: 27-32. (Pubitemid 351436957)
29. Saxena S, Car J, Eldred D, Soljak M, Majeed A (2007) Practice size, caseload, deprivation and quality of care of patients with coronary heart disease, hypertension and stroke in primary care: national cross-sectional study. BMC Health Serv Res 7: 96.
30. Hippisley-Cox J, O'Hanlon S, Coupland C (2004) Association of deprivation, ethnicity, and sex with quality indicators for diabetes: population based survey of 53,000 patients in primary care. BMJ 329: 1267-1269. (Pubitemid 39576731)
31. Millett C, Car J, Eldred D, Khunti K, Mainous AG, sd, et al. (2007) Diabetes prevalence, process of care and outcomes in relation to practice size, caseload and deprivation: national cross-sectional study in primary care. J R Soc Med 100: 275-283. (Pubitemid 46997765)
32. Millett C, Gray J, Saxena S, Netuveli G, Khunti K, et al. (2007) Ethnic Disparities in Diabetes Management and Pay-for-Performance in the UK: The Wandsworth Prospective Diabetes Study. PLoS Med 4: e191.
33. Wazana A (2000) Physicians and the Pharmaceutical Industry. JAMA: The Journal of the American Medical Association 283: 373-380.
34. Sbarbaro JA (2001) Can We Influence Prescribing Patterns? Clinical Infectious Diseases 33: S240-S244.
35. de Irala J, Osorio A, Carlos S, Lopez-del Burgo C (2011) Choice of birth control methods among European women and the role of partners and providers. Contraception 84: 558-564.
36. Lader D (2009) Opinions Survey Report No. 41: Contraception and Sexual Heath, 2008/09 Office for National Statistics, NHS Information Centre.
37. Mansour D (1994) Long-acting, reversible methods of contraception. Contemporary Reviews in Obstetrics and Gynaecology 6: 89-94.
38. Fleming CF (2009) Long-acting reversible contraceptives. The Obstetrician & Gynaecologist 11: 83-88.
39. Tanfer K, Wierzbicki S, Payn B (2000) Why are U.S. women not using longacting contraceptives? Family Planning Perspectives 32: 1762183+191.
40. Speidel JJ, Harper CC, Shields WC (2008) The potential of long-acting reversible contraception to decrease unintended pregnancy. Contraception 78: 197-200.
41. Wellings K, Zhihong Z, Krentel A, Barrett G, Glasier A (2007) Attitudes towards long-acting reversible methods of contraception in general practice in the UK. Contraception 76: 208-214. (Pubitemid 47247663)
42. Middleton AJ, Naish J, Singer N (2011) General practitioners' views on the use of the levonorgestrel-releasing intrauterine system in young, nulligravid women, in London, UK. The European Journal of Contraception and Reproductive Health Care 16: 311-318.
43. Halpern V, Lopez Laureen M, Grimes David A, Gallo Maria F (2011) Strategies to improve adherence and acceptability of hormonal methods of contraception. Cochrane Database of Systematic Reviews: John Wiley & Sons, Ltd.